|
Thyro-blockDrug - Thyro-block The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Potassium Iodide
Strength -
130MG
Applicant -
MEDPOINTE PHARM HLC
New Drug Application (NDA) Number -
018307
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Medpointe Pharmaceuticals Medpointe Healthcare Inc
Thyro-block
Tham-e 370mg/vial;1.75gm/vial;36gm/vial Injectable; Injection
Potassium Citrate 10meq/packet For Solution; Oral Potassium Citrate 20meq/packet For Solution; Oral Urocit-k 10meq Tablet, Extended Release; Oral Urocit-k 5meq Tablet, Extended Release; Oral Potassium Iodide 1gm/ml Solution; Oral Thyroshield 65mg/ml Solution; Oral Iosat 130mg Tablet; Oral Thyro-block 130mg Tablet; Oral Sodium Chloride 0.9% And Potassium Chloride 0.3% In Plastic Container 300mg/100ml;900mg/100ml Injectable; Injection NewDrugInformation |